January 26, 2023
Aspiring to deliver new cures for complex conditions
Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides in accelerating science to make and deliver regenerative biotherapeutics. The goal is to offer new options, based on rigorous research in cell and gene therapies, for disorders with few available […]
Tags: 3D bioprinting, biologics, biomanufacturing, CAR-T cell therapy, Center for Regenerative Biotherapeutics, Julie Allickson, purified exosome product, stromal vascular fraction cells, tissue engineering
August 30, 2022
Biomanufacturing 101: Understanding a new era of therapeutics
Advancing discoveries such as cellular therapies from clinical trials to commercial therapy is a cornerstone of Mayo Clinic’s strategic emphasis on biomanufacturing. The long-term vision is to provide new cures for patients with unmet needs. “Biomanufacturing is a type of manufacturing that utilizes sources from the human body — cells, blood, enzymes, tissues, genes or […]
Tags: biologics, biomanufacturing, CAR-T cell therapy, Center for Regenerative Medicine, Julie Allickson, regnerative biotherapeutics
July 28, 2022
Bringing regenerative technology of the future to patients today
“The sky’s the limit,” “possibility” and “potential cure for disease” are aspirational ways Mayo Clinic physicians and scientists described regenerative medicine in a recent virtual presentation at the World Stem Cell Summit 2022. Mayo’s panel discussion showcased how it is advancing regenerative medicine through industry collaborations that accelerate scientific discoveries to early stage clinical trials. […]
Tags: 3D printing, Abba Zubair, biomanufacturing, Center for Regenerative Medicine, David Lott, Julie Allickson, Saranya Wyles, tissue engineering, World Stem Cell Summit
March 14, 2022
The regenerative operating room of the future
Envisioning the future of regenerative medicine elicits images of an operating room that also is a manufacturing facility. Patients undergoing surgery could have immediate access to products biomanufactured within the operating room or even within their own bodies. Products such as tissue engineered for targeted healing or 3D-printed scaffolds that repair diseased organs, bones or […]
Tags: 3D printing, biomanufacturing, Brittany Howard, Center for Regenerative Medicine, David Lott, Juergen Neubauer, laryngeal cancer, larynx transplant, Michael McPhail, Richard Hayden, tissue engineering
December 27, 2021
A year of new directions and advancements for regenerative medicine
2021 has been a year of significant innovation across the field of regenerative medicine at Mayo Clinic. Important advancements in preclinical research, as well as new regenerative treatments for patients, further are solidifying Mayo Clinic’s reputation as a world-class leader in regenerative medicine. Regenerative medicine is still a relatively new field of practice, representing a […]
Tags: biomanufacturing, Center for Regenerative Medicine, Janani Reisenauer, Julie Allickson, regenerative medicine, Saad Kenderian
November 19, 2021
Mayo Clinic Symposium on Regenerative Medicine & Surgery recap
“The future of regenerative medicine is bright,” declared Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, as she delivered the opening keynote address of the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021. Dr. Allickson is the Otto Bremer Trust Director, Biomanufacturing and Product […]
Tags: biomanufacturing, Center for Regenerative Medicine, Julie Allickson, Peter Marks, Richard Gray, Richard Hayden
January 5, 2021
Looking back on 2020: A successful year of research at Mayo Clinic in Florida
By Advancing the Science contributor
At Mayo Clinic, Research and Education provide the basis for all we are able to do for patients today. Furthermore, they enable practice transformation as we seek to meet future patient needs. From new capabilities in cell therapy and immunotherapy, to advances in neurodegenerative diseases and studies of the virus that causes COVID-19, research at Mayo Clinic continued […]
Tags: Alzheimer's disease, Ben Pollock, biomanufacturing, biomarkers, biostatistics, brain, cancer, CAR-T cell therapy, carbon ion therapy, Center for Regenerative Medicine, chemotherapy, clinical research
October 23, 2019
By Jen Schutz
With growing public awareness and broader academic engagement, the prospect of pioneering a change in disease management has propelled the field of regenerative medicine. The ability to build, scale and apply biotherapeutic technologies and solutions that are not cost prohibitive will become increasingly important elements that drive progress in regenerative medicine. In a recently published paper, […]
Tags: Andre Terzic, Atta Behfar, biomanufacturing, Center for Regenerative Medicine, stem cells
October 17, 2019
Florida building dedicated to medical discovery and innovation
By Jen Schutz
The grand opening of the new Discovery and Innovation Building at Mayo Clinic’s Florida campus signals a new era of integrating regenerative medicine into daily practice. Regenerative medicine seeks to tap the body’s ability to replace, restore or regrow damaged or diseased cells, tissues and organs. A hub of research and technology, the new building […]
Tags: Abba Zubair, Atta Behfar, biomanufacturing, Center for Regenerative Medicine, discovery research, lung transplant, Mayo Clinic Life Science Incubator, medical innovation, regenerative medicine, stem cells